SedaToluMD Profile Banner
Seda Tolu Profile
Seda Tolu

@SedaToluMD

Followers
182
Following
289
Media
5
Statuses
30

Hematology & Oncology at Columbia University Irving Medical Center @ColumbiaCancer. Lymphoma clinical trials and translational research

Joined April 2022
Don't wanna be here? Send us removal request.
@SedaToluMD
Seda Tolu
1 year
Amazing mentorship makes amazing things possible! Canโ€™t wait to see whatโ€™s next and so grateful to be part of this team ๐Ÿ˜Š@jenamengual @bpromd @hjcherng @columbiacancer #ASH24
@jenamengual
Jennifer Amengual
1 year
So proud of you!! Lucky to be working w you @columbiacancer - beautiful organoids to help #curelymphoma!
0
0
13
@SedaToluMD
Seda Tolu
1 year
Reuniting and look forward for whats next!! #ASH24 #CRTI
@jenamengual
Jennifer Amengual
1 year
#ASH24 #CRTI reunion with Matt Mauer and @SedaToluMD - working on forming new collaborations! #curelymphoma
1
0
2
@SedaToluMD
Seda Tolu
1 year
One small lab, two big orals at ASH2024! @jenamengual and Ted Piorczynski. ๐Ÿ‘๐Ÿผ๐Ÿ™Œ๐Ÿผ
1
1
30
@SedaToluMD
Seda Tolu
1 year
So excited to share this work on targeting 9p+ Lymphomas at ASH 2024!
@bpromd
Barbara Pro
1 year
Combination JAK inhibition and Immune checkpoint blockade being presented by @SedaToluMD ๐Ÿ‘ @columbiacancer #ASH2024 #ASH24
3
4
17
@oncodaily
OncoDaily
1 year
Unlocking the potential of epigenetic therapies! @SedaToluMD and colleagues explore the promise of combining epigenetic agents with other treatments to enhance outcomes in @NatRevClinOncol https://t.co/8CK4SB2M3r @TheDoctorIsVin @jenamengual @bpromd @susanebates #Cancer
0
4
27
@SedaToluMD
Seda Tolu
2 years
Woo! Lucky to have such great mentorship! ๐Ÿ‘๐Ÿผ๐Ÿ™Œ๐Ÿผ
@jenamengual
Jennifer Amengual
2 years
What a Week for @Columbiacancer Lymphoma Mentees! Alex Sanjurjo MedStud: ASH HONORs @patrickwgould IMResident: Top 4 @ Residents Research Day Ted Piorczynski PostDoc: Winner Columbia University Postdoc Research Symposium @SedaToluMD HemOnc Fellow: ASH RTAF #curelymphoma
3
0
9
@AlexandraRojek
Alexandra Rojek
2 years
Excited to participate in the first #HOPLive24 with @chadinabhan and share our experiences as fellows in heme malignancies! @UChicagoHemOnc
@Blood_Cancers
Blood Cancers Today
2 years
0
2
16
@SedaToluMD
Seda Tolu
2 years
An amazing presentation on all things T-cell Lymphoma with great discussion on management, role stem cell transplant, and future directions๐Ÿ‘๐Ÿผ๐Ÿ‘๐Ÿผ@bpromd @DrAEvens @columbiacancer @MediHumdani #HOPLive24
0
5
22
@doctorpemm
Naveen Pemmaraju, MD
2 years
#HOPLive24 #HemOnc Pulse | Awesome T-cell Lymphoma session led by Dr Barbara Pro @bpromd ๐Ÿ‘ @chadinabhan @sanamloghavi @MediHumdani @DrAEvens @mshadman @ASkarbnik #lymsm @mpdrc
0
5
16
@SedaToluMD
Seda Tolu
2 years
Such a fun experience!! #HOPLive24
@bpromd
Barbara Pro
2 years
On stage! @SedaToluMD @columbiacancer ๐Ÿ‘
1
1
17
@hjcherng
Hua-Jay (Jeff) Cherng
2 years
Fun commentary we wrote on CD20 loss after bispecific antibodies in response to Schuster et al ( https://t.co/fSSZ3RomOg), see if you can find all the puns! #lymsm โฆ@BloodJournalโฉ
Tweet card summary image
ashpublications.org
Schuster SJ, Huw LY, Bolen CR, . Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood. 2023
0
4
18
@SedaToluMD
Seda Tolu
2 years
Great discussion tonight on everything Leukemia and Lymphoma from the experts in the field!!! @jenamengual @hjcherng @andrewlipskymd @Sunil_G_Iyer @JoeJurcic @columbiacancer @OncLive ๐ŸŽ‰โญ๏ธ
0
1
17
@SedaToluMD
Seda Tolu
2 years
Thatโ€™s a wrap #ASH23! Presented our 2nd poster on outcomes by race in PTCL - great work with Alex Sanjurjo! @ColumbiaPS @columbiacancer โญ๏ธโญ๏ธโญ๏ธ And so grateful to catch up with amazing friends & colleagues. The future of hematology is bright! โ˜€๏ธ
0
0
13
@jenamengual
Jennifer Amengual
2 years
Nice #ASH2023 poster by Tony Pazosโ€”exploring JAKinh ruxolitinib + epigenetic targeting in T cell lymphoma. @columbiacancer #curelymphoma
0
2
8
@jenamengual
Jennifer Amengual
2 years
We missed Ted Piorczynski at #ASH2023 this year but his poster on dual epigenetic modulation of GC reaction and immune activation very intriguing! @columbiacancer #curelymphoma
0
1
6
@jenamengual
Jennifer Amengual
2 years
Thrilled to be working with such a fantastic team! @nyphospital @WeillCornell @columbiacancer #curelymphoma
@SedaToluMD
Seda Tolu
2 years
Excited to present our joint efforts in R/R PTCL between Columbia & Cornell at ASH! Incredibly grateful for my amazing mentorship with @jenamengual @bpromd and Dr Ruan + collaboration with @CaitieGribbinMD! More great things to come! ๐ŸŽ‰@columbiacancer @WeillCornell @nyphospital
1
1
20
@SedaToluMD
Seda Tolu
2 years
What an incredible honor!! Huge thank you to the Cutaneous Lymphoma Foundation and my amazing mentors @bpromd & Dr. Geskin! ๐ŸŽ‰๐ŸŽ‰ #CLF #ASH23
@bpromd
Barbara Pro
2 years
Very proud of our ๐ŸŒŸchief fellow @SedaSerraTolu for receiving the young investigator award from the cutaneous lymphoma foundation ๐Ÿ‘@columbiacancer @nyphospital @skinlymphoma #ASH23
3
2
33
@SedaToluMD
Seda Tolu
2 years
Excited to present our joint efforts in R/R PTCL between Columbia & Cornell at ASH! Incredibly grateful for my amazing mentorship with @jenamengual @bpromd and Dr Ruan + collaboration with @CaitieGribbinMD! More great things to come! ๐ŸŽ‰@columbiacancer @WeillCornell @nyphospital
1
3
32
@jenamengual
Jennifer Amengual
2 years
Forgot the link! https://t.co/CsJ3LW33UE
Tweet card summary image
ashpublications.org
Amengual and Pro present their approach to posttransplant lymphoproliferative disease (PTLD), complicating solid organ transplant and hematopoietic cell tr
@jenamengual
Jennifer Amengual
2 years
Check it out! Hot off the press in Blood @BloodJournal : How I Treat PTLD. Honor to work on this manuscript with Barbara Pro @bpromd ! @columbiacancer #curelymphoma
0
1
7
@SedaToluMD
Seda Tolu
2 years
Had a blast presenting at the New York Lymphoma Rounds tonight! So lucky to learn from leaders and canโ€™t wait for next time! ๐ŸŽ‰๐ŸŽ‰๐ŸŽ‰
@YLeyfman
Yan Leyfman, MD
2 years
๐Ÿ’ซGreatly enjoying learning from rising ๐ŸŒŸ Dr. Seda Tolu from Columbia Cancer Center as she discussed a unique approach to treat r/r transformed MZL at Lymphoma Rounds. Thank you to organizers Dr. Andrew Lipsky and Dr. David Straus for curating this enriching program.
0
0
9